aap Implantate AG
XETRA: AAQ1.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Rubino Di Girolamo
- Employees
- 87
- Headquarters
- Berlin, Germany
- IPO year
- 1999
- Market cap
- €30.3M
- Website
- https://www.aap.de
Loading AAQ1…
Loading profile data…Frequently asked questions about AAQ1
What does aap Implantate AG (AAQ1.DE) do?
aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospi...
Where does AAQ1.DE trade?
aap Implantate AG (AAQ1.DE) trades on the Deutsche Börse.
What sector is AAQ1.DE in?
aap Implantate AG (AAQ1.DE) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of aap Implantate AG?
Rubino Di Girolamo is the chief executive officer of aap Implantate AG (AAQ1.DE).
Where is aap Implantate AG headquartered?
aap Implantate AG is headquartered in Germany.
Does AAQ1.DE pay a dividend?
aap Implantate AG (AAQ1.DE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AAQ1.DE go public?
aap Implantate AG (AAQ1.DE) completed its initial public offering in 1999.